000 01280 a2200337 4500
005 20250517083122.0
264 0 _c20160630
008 201606s 0 0 eng d
022 _a1941-3084
024 7 _a10.1161/CIRCEP.115.002479
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHanley, Colleen M
245 0 0 _aStatus of Antiarrhythmic Drug Development for Atrial Fibrillation: New Drugs and New Molecular Mechanisms.
_h[electronic resource]
260 _bCirculation. Arrhythmia and electrophysiology
_cMar 2016
300 _ae002479 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAction Potentials
650 0 4 _aAnimals
650 0 4 _aAnti-Arrhythmia Agents
_xadverse effects
650 0 4 _aAtrial Fibrillation
_xdiagnosis
650 0 4 _aDrugs, Investigational
_xadverse effects
650 0 4 _aHeart Conduction System
_xdrug effects
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aTreatment Outcome
700 1 _aRobinson, Victoria M
700 1 _aKowey, Peter R
773 0 _tCirculation. Arrhythmia and electrophysiology
_gvol. 9
_gno. 3
_gp. e002479
856 4 0 _uhttps://doi.org/10.1161/CIRCEP.115.002479
_zAvailable from publisher's website
999 _c25790372
_d25790372